Back to Search
Start Over
SF1-4 from Treatment of Pancreatic Cancer Patient–Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- SF 1. Heat map showing the tumor growth inhibition (TGI) of six metabolic inhibitors in PDX panel. SF 2. Tumor growth curves of PDXs treated with phenformin. SF 3. Tumor doubling time of 12 individual PDXs. SF 4. Aggregate tumor doubling time of PDXs treated with vehicle or phenformin.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....2aff6cabfe1685785d8cd3b8aca1963d
- Full Text :
- https://doi.org/10.1158/1078-0432.22468770